ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
Yf-Vax 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 8%로 성장할 전망이며, 91억 2,000만 달러로 성장이 예측됩니다. 이 예측 기간의 성장은 신흥국의 백신 접종 수요 증대, 백신 유통 채널 진보, 정부 주최 백신 접종 프로그램, 백신 유통 인프라의 지속적인 진보, 백신 제제와 입수 가능성 개선 등에 기인하고 있습니다. 예측 기간의 주요 동향에는 제품 승인, 파트너십, 황색 백신 개발 등이 있습니다.
매개 질환에 대한 의식 증가는 Yf-Vax 시장의 확대를 촉진할 것으로 예측됩니다. 매개성 질환은 모기, 진드기, 벼룩 등의 감염 절지동물에 물림으로써 사람이나 동물에게 퍼지는 감염병으로 바이러스, 세균, 기생충 등의 병원체를 매개하여 말라리아, 뎅기열, 라임병 등의 질병을 일으킵니다. 이러한 질병의 유행이 증가하고 있는 배경에는 기후변화, 도시화, 세계여행 증가, 모기 개체수의 증가 등이 있으며, 그 결과 더 자주 발생하게 되고 있습니다. Yf-Vax는 면역계를 자극하여 항체를 생산하게 하고 감염된 모기가 매개하는 바이러스로부터 장기간에 걸쳐 몸을 보호함으로써 매개 감염병인 황열병의 예방에 도움이 됩니다. 예를 들어 2024년 3월 세계동물보건기구는 2023-2024년 3월까지 28개국에서 2,422건의 매개 감염병 발생을 보고했고, 유럽에서는 697건의 발생이 있었습니다. 매개성 질환에 대한 의식의 고조가 Yf-Vax 시장의 성장에 기여하고 있습니다.
헬스케어 지출 증가가 Yf-Vax 시장의 성장을 견인할 것으로 예측됩니다. 고령화, 의료기술의 진보, 만성질환의 만연, 헬스케어 서비스에 대한 수요 증가와 같은 요인들이 헬스케어 지출 증가에 기여하고 있습니다. Yf-Vax는 황열병의 중증화를 예방함으로써 치료, 입원, 아웃브레이크 관리와 관련된 비용을 절감하고 헬스케어 비용 절감에 기여합니다. 예를 들면, 2024년 5월, 영국의 국가통계국은 2022-2023년 의료비가 5.6% 증가했다고 보고했습니다(2022년의 성장은 0.9%). 2023년 영국의 헬스케어 지출은 3,176억 3,000만 달러(2,920억 파운드)에 달했습니다. 그 결과, 헬스케어 지출의 증가가 Yf-Vax 시장의 성장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 바이오의약품 시장에서의 제품 특성
분자 유형
투여 경로(ROA)
작용기전(MOA)
안전성 및 유효성
제4장 시장 동향 및 전략
제5장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제6장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 Yf-Vax : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 Yf-Vax 시장 : 성장률 분석
세계의 Yf-Vax 시장 실적 : 규모 및 성장(2019-2024년)
세계의 Yf-Vax 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 Yf-Vax : 전체 시장 규모(TAM)
제7장 세계의 시장 가격 분석 및 예측
제8장 시장 세분화
세계의 Yf-Vax 시장 : 백신 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
생약독화 백신
분할 투여 백신
세계의 Yf-Vax 시장 : 감염 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
삼림 황열병
중간형 황열병
도시형 황열병
세계의 Yf-Vax 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
소매 약국
정부의 건강 프로그램
세계의 Yf-Vax 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
성인
고령자
소아
제9장 세계의 임상적응증 시장 역학
약제의 부작용
임상적응증의 발병률 및 유병률
제10장 지역별 및 국가별 분석
세계의 Yf-Vax 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 Yf-Vax 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 경쟁 구도 및 기업 프로파일
Yf-Vax 시장 : 경쟁 구도
Yf-Vax 시장 : 기업 프로파일
Sanofi SA
제29장 세계 시장 : 파이프라인 분석
제30장 세계 시장 경쟁 벤치마킹 및 대시보드
제31장 주요 인수합병(M&A)
제32장 최근 시장 동향
제33장 시장의 잠재력이 높은 국가, 부문 및 전략
Yf-Vax 시장(2029년) : 새로운 기회를 제공하는 국가
Yf-Vax 시장(2029년) : 새로운 기회를 제공하는 부문
Yf-Vax 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제34장 부록
AJY
영문 목차
영문목차
YF-Vax is a live-attenuated vaccine developed to offer long-term protection against yellow fever, a serious viral illness transmitted by infected mosquitoes. It is frequently recommended for travelers and residents in areas where the disease is endemic.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary forms of YF-Vax include live-attenuated vaccines and fractional dose vaccines. Live-attenuated vaccines consist of weakened, yet live, versions of the virus or bacteria responsible for the disease. The disease can be transmitted through different types: sylvatic yellow fever, intermediate yellow fever, and urban yellow fever. These vaccines are available through multiple distribution channels, such as hospitals, retail pharmacies, and government health programs, and are used by various age groups, including adults, the elderly, and children.
The Yf-Vax market research report is one of a series of new reports from The Business Research Company that provides Yf-Vax market statistics, including Yf-Vax industry global market size, regional shares, competitors with a Yf-Vax market share, detailed Yf-Vax market segments, market trends, and opportunities, and any further data you may need to thrive in the Yf-Vax industry. This Yf-Vax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The Yf-Vax market size is expected to see strong growth in the next few years. It will grow to $9,120 million in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to growing demand for vaccination in emerging economies and advancements in vaccine distribution channels, government-sponsored vaccination programs, ongoing advancements in vaccine distribution infrastructure, and improvements in vaccine formulations and availability. Major trends in the forecast period include product approvals, partnerships and developments in yellow vaccine.
The growing awareness of vector-borne diseases is expected to drive the expansion of the yf-vax market. Vector-borne diseases are infectious conditions spread to humans and animals through the bites of infected arthropods, such as mosquitoes, ticks, and fleas, which carry pathogens like viruses, bacteria, or parasites, leading to illnesses such as malaria, dengue, and Lyme disease. The rise in the prevalence of these diseases is attributed to factors like climate change, urbanization, increased global travel, and the expansion of mosquito populations, resulting in more frequent outbreaks. YF-Vax helps prevent yellow fever, a vector-borne disease, by stimulating the immune system to produce antibodies that provide long-lasting protection against the virus spread by infected mosquitoes. For example, in March 2024, the World Organization for Animal Health reported 2,422 outbreaks of vector-borne diseases across 28 countries from 2023 to March 2024, with Europe experiencing 697 outbreaks. As awareness of vector-borne diseases rises, it is contributing to the growth of the yf-vax market.
The increasing healthcare spending is expected to drive the yf-vax market's growth. Factors such as an aging population, advancements in medical technology, the growing prevalence of chronic diseases, and higher demand for healthcare services are contributing to rising healthcare expenditures. YF-VAX helps reduce healthcare costs by preventing severe yellow fever infections, which lowers expenses associated with treatment, hospitalizations, and outbreak management. For instance, in May 2024, the Office for National Statistics in the UK reported that healthcare spending grew by 5.6% from 2022 to 2023, compared to 0.9% growth in 2022. The UK's healthcare expenditure amounted to $317.63 billion (£292 billion) in 2023. Consequently, the rise in healthcare spending is fostering the growth of the yf-vax market.
A notable trend in the yf-vax market is the adoption of strategic partnerships to enhance technological integration and expand market presence. Strategic partnerships involve collaborations between organizations, where they combine resources, expertise, and efforts to achieve mutual goals. For example, in March 2022, the International Finance Corporation (IFC), a US-based financial services company, partnered with Institut Pasteur de Dakar (IPD), a Senegal-based yellow fever vaccine manufacturer, to establish a vaccine manufacturing facility in Senegal. The $222 million project, financed through a combination of public, private, and grant funding, will significantly boost IPD's production capacity, initially focusing on COVID-19 vaccines, with plans to expand to other vaccines. Once fully operational, the facility aims to produce up to 300 million doses annually for Africa.
Major players operating in the yf-vax market are Sanofi S.A
North America was the largest region in the yf-vax market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in yf-vax report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the yf-vax market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The yf-vax market consists of sales of vaccine syringes, pre-filled injection devices, and immunization kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Yf-Vax Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on yf-vax market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for yf-vax ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The yf-vax market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Vaccine Type: Live Attenuated Vaccines; Fractional Dose Vaccine
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Yf-Vax Market Characteristics
3. Yf-Vax Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Yf-Vax Market Trends And Strategies
5. Yf-Vax Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Yf-Vax Growth Analysis And Strategic Analysis Framework
6.1. Global Yf-Vax PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Yf-Vax Market Growth Rate Analysis
6.4. Global Yf-Vax Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Yf-Vax Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Yf-Vax Total Addressable Market (TAM)
7. Global Yf-Vax Market Pricing Analysis & Forecasts
8. Yf-Vax Market Segmentation
8.1. Global Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Attenuated Vaccines
Fractional Dose Vaccines
8.2. Global Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sylvatic Yellow Fever
Intermediate Yellow Fever
Urban Yellow Fever
8.3. Global Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Retail Pharmacies
Government Health Programs
8.4. Global Yf-Vax Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adult
Geriatric
Pediatric
9. Global Yf-Vax Market Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Yf-Vax Market Regional And Country Analysis
10.1. Global Yf-Vax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Yf-Vax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Yf-Vax Market
11.1. Asia-Pacific Yf-Vax Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Asia-Pacific Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Asia-Pacific Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Yf-Vax Market
12.1. China Yf-Vax Market Overview
12.2. China Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.3. China Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.4. China Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Yf-Vax Market
13.1. India Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. India Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. India Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Yf-Vax Market
14.1. Japan Yf-Vax Market Overview
14.2. Japan Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. Japan Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. Japan Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Yf-Vax Market
15.1. Australia Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.2. Australia Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Australia Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Yf-Vax Market
16.1. South Korea Yf-Vax Market Overview
16.2. South Korea Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. South Korea Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.4. South Korea Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Yf-Vax Market
17.1. Western Europe Yf-Vax Market Overview
17.2. Western Europe Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Western Europe Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.4. Western Europe Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Yf-Vax Market
18.1. UK Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. UK Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. UK Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Yf-Vax Market
19.1. Germany Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Germany Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Germany Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Yf-Vax Market
20.1. France Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. France Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. France Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Yf-Vax Market
21.1. Eastern Europe Yf-Vax Market Overview
21.2. Eastern Europe Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Yf-Vax Market
22.1. North America Yf-Vax Market Overview
22.2. North America Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. North America Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.4. North America Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Yf-Vax Market
23.1. USA Yf-Vax Market Overview
23.2. USA Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. USA Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. USA Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Yf-Vax Market
24.1. Canada Yf-Vax Market Overview
24.2. Canada Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. Canada Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. Canada Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Yf-Vax Market
25.1. South America Yf-Vax Market Overview
25.2. South America Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. South America Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. South America Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Yf-Vax Market
26.1. Middle East Yf-Vax Market Overview
26.2. Middle East Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. Middle East Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. Middle East Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Yf-Vax Market
27.1. Africa Yf-Vax Market Overview
27.2. Africa Yf-Vax Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Africa Yf-Vax Market, Segmentation By Transmission Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.4. Africa Yf-Vax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Yf-Vax Market Competitive Landscape And Company Profiles
28.1. Yf-Vax Market Competitive Landscape
28.2. Yf-Vax Market Company Profiles
28.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
29. Global Yf-Vax Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Yf-Vax Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Yf-Vax Market
32. Recent Developments In The Yf-Vax Market
33. Yf-Vax Market High Potential Countries, Segments and Strategies
33.1 Yf-Vax Market In 2029 - Countries Offering Most New Opportunities
33.2 Yf-Vax Market In 2029 - Segments Offering Most New Opportunities
